Scholar Rock Holding Corp. (SRRK)
50.62
-0.88
(-1.72%)
USD |
NASDAQ |
May 27, 16:00
50.62
0.00 (0.00%)
After-Hours: 17:39
Scholar Rock Cash from Investing (Quarterly) : -5.335M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen, Inc. | -209.50M |
| Apellis Pharmaceuticals, Inc. (DELISTED) | 0.00 |
| Viking Therapeutics, Inc. | 54.19M |
| BridgeBio Pharma, Inc. | -42.74M |
| Mirum Pharmaceuticals, Inc. | -11.57M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -82.10M |
| Cash from Financing (Quarterly) | 193.79M |
| Free Cash Flow | -303.86M |
| Free Cash Flow Per Share (Quarterly) | -0.6456 |
| Free Cash Flow to Equity (Quarterly) | -178.93M |
| Free Cash Flow to Firm (Quarterly) | -79.87M |
| Free Cash Flow Yield | -5.26% |